Evidence map›Paper›PMID 41171907›Full record

ReviewScience advances2025

Unlocking the therapeutic potential of cellular mechanobiology.

Yohalie Kalukula, Giuseppe Ciccone, Danahe Mohammed, Anthony Procès, Marie Versaevel, Amandine Deridoux, Lucie Ergot, Zoé Barbier, Maxime Mansy, Roxane Aucouturier and 4 more

Abstract readReview
In one paragraph

Review in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Bridging nanotechnology and mechanobiology.Nature nanotechnology · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yohalie KalukulaSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0002-4429-2995
Giuseppe CicconeSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0002-7677-6257
Danahe MohammedSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0002-2612-7670
Anthony ProcèsUniversity Grenoble Alpes, INSERM U1216, Grenoble Alpes, Grenoble Institut Neuroscience, 38000 Grenoble, France.ORCID 0000-0002-4785-8931
Marie VersaevelSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0003-0710-4243
Amandine DeridouxSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0003-0540-1500
Lucie ErgotSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0009-0008-8886-1708
Zoé BarbierSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0009-0006-4491-2919
Maxime MansySYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0009-0005-8279-6640
Roxane AucouturierSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0009-0003-6626-2185
Rémi TranzerSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0009-0008-6995-0975
Mathieu SurinLaboratory for Chemistry of Novel Materials, CIRMAP, University of Mons-UMONS, Mons, Belgium.ORCID 0000-0001-8950-3437
Sylvain GabrieleSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0001-8696-8052
Marine LucianoSYMBIOSE Lab, Research Institute for Biosciences, Research Institute for Materials Science and Engineering, CIRMAP, University of Mons-UMONS, B-7000 Mons, Belgium.ORCID 0000-0003-0826-9752

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanobiology is a rapidly advancing field at the intersection of biology, physics, and engineering that reveals how mechanical forces shape cellular behavior, tissue architecture, and disease progression. By elucidating how cells sense and transduce mechanical cues, mechanobiology has fundamentally advanced our understanding of processes ranging from migration and differentiation to immune responses and tissue remodeling. These advances have driven the development of innovative biophysical tools and engineered biomaterials that enable precise modulation of the cellular microenvironment. Translating mechanobiological principles into clinical practice is giving rise to mechanomedicine, a previously unrecognized paradigm that integrates mechanical forces as key modulators of health and disease. This review highlights how mechanobiology informs therapeutic strategies across diverse domains, including cancer immunotherapy, cardiovascular and neurodegenerative disorders, and regenerative medicine. By bridging fundamental discoveries with translational applications, this review positions mechanobiology as a cornerstone of next-generation medical innovation, translating mechanistic insights into impactful clinical applications.

Indexed as

BiophysicsMechanotransduction, CellularAnimalsBiocompatible MaterialsBiomechanical PhenomenaHumansNeoplasmsNeurodegenerative DiseasesRegenerative MedicineBiocompatible Materials

Identifiers

PMID41171907
PMCPMC12577691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.